Spots Global Cancer Trial Database for prostate carcinoma metastatic in the bone

Every month we try and update this database with for prostate carcinoma metastatic in the bone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer	NCT03821792	Metastatic Pros... Prostate Adenoc... Prostate Carcin... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Apalutamide Prednisone	18 Years -	M.D. Anderson Cancer Center
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression	NCT02555189	Castration-Resi... Metastatic Pros... Prostate Carcin... Stage IV Prosta...	Enzalutamide Ribociclib Laboratory Biom... Pharmacological... Biospecimen Col... Biopsy Echocardiograph... Multigated Acqu... Bone Scan Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency	NCT03442556	ATM Gene Mutati... BRCA1 Gene Muta... BRCA2 Gene Muta... Castration Leve... Castration-Resi... Homologous Reco... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta...	Carboplatin Docetaxel Laboratory Biom... Rucaparib Camsy... Rucaparib	18 Years -	University of Washington
Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer	NCT02215161	Castration Leve... Hormone-Resista... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta...	Selinexor	18 Years -	University of California, San Francisco
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03709550	Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine Enzalutamide	18 Years -	Roswell Park Cancer Institute
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression	NCT02555189	Castration-Resi... Metastatic Pros... Prostate Carcin... Stage IV Prosta...	Enzalutamide Ribociclib Laboratory Biom... Pharmacological... Biospecimen Col... Biopsy Echocardiograph... Multigated Acqu... Bone Scan Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer	NCT03344211	Castration-Resi... Prostate Carcin... Stage IV Prosta...	Enzalutamide Laboratory Biom... Radium Ra 223 D...	18 Years -	University of Southern California
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies	NCT03217747	Advanced Malign... Castration-Resi... Malignant Solid... Metastatic Mali... Metastatic Pros... Prostate Carcin... Refractory Mali... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Avelumab Ivuxolimab Radiation Thera... Utomilumab	18 Years -	M.D. Anderson Cancer Center
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03709550	Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine Enzalutamide	18 Years -	Roswell Park Cancer Institute
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03406858	Castration Leve... Castration-Resi... Prostate Carcin... PSA Progression Stage IV Prosta...	HER2Bi-Armed Ac... Laboratory Biom... Pembrolizumab	19 Years -	Barbara Ann Karmanos Cancer Institute
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer	NCT03821792	Metastatic Pros... Prostate Adenoc... Prostate Carcin... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Apalutamide Prednisone	18 Years -	M.D. Anderson Cancer Center
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03406858	Castration Leve... Castration-Resi... Prostate Carcin... PSA Progression Stage IV Prosta...	HER2Bi-Armed Ac... Laboratory Biom... Pembrolizumab	19 Years -	Barbara Ann Karmanos Cancer Institute
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03751436	Castration Leve... Castration-Resi... Metastatic Pros... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Enzalutamide Venetoclax	18 Years -	Roswell Park Cancer Institute
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate	NCT03582475	Bladder Small C... Castration-Resi... Metastatic Blad... Metastatic Uret... Prostate Carcin... Prostate Neuroe... Prostate Small ... Stage III Bladd... Stage III Prost... Stage III Ureth... Stage IV Bladde... Stage IV Prosta... Stage IV Urethr... Stage IVA Bladd... Stage IVB Bladd... Ureter Small Ce... Urothelial Carc...	Carboplatin Cisplatin Docetaxel Etoposide Pembrolizumab	18 Years -	Jonsson Comprehensive Cancer Center
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord	NCT02713269	Malignant Diges... Metastatic Head... Metastatic Kidn... Metastatic Mali... Metastatic Mali... Metastatic Mela... Prostate Carcin... Sarcoma Solid Neoplasm Spinal Cord Com... Stage IV Breast... Stage IV Lung N... Thyroid Gland C...	Computed Tomogr... Quality-of-Life... Questionnaire A... Stereotactic Ra... Thermal Ablatio...	18 Years -	M.D. Anderson Cancer Center
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression	NCT02555189	Castration-Resi... Metastatic Pros... Prostate Carcin... Stage IV Prosta...	Enzalutamide Ribociclib Laboratory Biom... Pharmacological... Biospecimen Col... Biopsy Echocardiograph... Multigated Acqu... Bone Scan Computed Tomogr... Magnetic Resona...	18 Years -	Thomas Jefferson University
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03709550	Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine Enzalutamide	18 Years -	Roswell Park Cancer Institute
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03751436	Castration Leve... Castration-Resi... Metastatic Pros... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Enzalutamide Venetoclax	18 Years -	Roswell Park Cancer Institute
Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone	NCT03707184	Metastatic Pros... Prostate Carcin... Stage IV Prosta...	Computed Tomogr... Fluciclovine F1... Positron Emissi...	-	University of Utah

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: